<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294617</url>
  </required_header>
  <id_info>
    <org_study_id>P30CA072720</org_study_id>
    <nct_id>NCT02294617</nct_id>
  </id_info>
  <brief_title>E-cigarette vs. Nicotine Inhaler Comparisons</brief_title>
  <official_title>Comparative Evaluation of the Perceptions and Utilization of Nicotine Inhalation Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to get information from current smokers about how they feel towards
      both the electronic cigarette (e-cigarette) and the nicotine oral inhaler. This will include
      beliefs, harms, appeal, ease of use, enjoyment, and their use for helping people stop
      smoking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be seen at Baseline, then 3-days post-baseline, then 9 days post-baseline for
      post product use questionnaires and carbon monoxide monitoring. The time frame for follow up
      is 6 months post Baseline visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceptions about devices</measure>
    <time_frame>6 months (August 2012-December 2013)</time_frame>
    <description>The goal of this study is to gather data from current smokers regarding their perceptions and experiences with both the e-cigarette and the nicotine oral inhaler over a 6 month time period.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>Nicotrol Inhaler</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will use the Nicotine Inhaler for 3 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic Cigarette</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will use the electronic cigarette for 3 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic Cigarette</intervention_name>
    <description>Subject will use electronic cigarette for 3 days.</description>
    <arm_group_label>Electronic Cigarette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nicotrol Inhaler</intervention_name>
    <description>Subjects will use the Nicotrol Inhaler for 3 days.</description>
    <arm_group_label>Nicotrol Inhaler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects will be smokers 18 years or older, who have had no previous experience with
             either the e-cigarette or the nicotine oral inhaler, and will be recruited from the
             local community. They can currently smoke any amount or frequency and with any level
             of motivation to stop smoking.

        Exclusion Criteria:

          -  Exclusion criteria include recent (within 2 weeks) myocardial infarction or angina,
             poorly controlled asthma/chronic obstructive pulmonary disease , active substance
             abuse, pregnancy, or current use of any other cessation medications
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2014</study_first_submitted>
  <study_first_submitted_qc>November 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Michael B. Steinberg, MD, MPH, FACP</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

